Evaluation of the Effectiveness of Ultrasonography-Guided Pulsed Radiofrequency to the Suprascapular Nerve in the Treatment of Adhesive Capsulitis in Elderly Patients
pain
1 other identifier
observational
32
1 country
1
Brief Summary
Adhesive Capsulitis (AC) is a condition that restricts the passive and active range of motion of the shoulder joint, impairing quality of life and activities. AC, which can be progressive and last a long time, is also called "frozen shoulder." The incidence of AC is 2-4% in the normal patient population. This rate varies between 10-30% in diabetic patients. The limitation and pain in AC joint range of motion (ROM) can last up to 3 years. There is no clear data on its prevalence in elderly patients. Its etiopathogenesis has not been fully elucidated. Fibrotic contractures form in the joint capsule. Diabetes, female gender, autoimmune diseases, thyroid disorders, immobilization, cardiovascular and cerebrovascular diseases, and advanced age are among the risk factors . AC is often diagnosed by physical examination and exclusion of other joint pathologies. Magnetic resonance imaging (MRI) can be helpful in diagnosis . Physical therapy, medical, interventional methods, and surgery are used in the treatment of AC. In physical therapy, exercises and modalities aimed at increasing ROM are used, while medical treatment includes oral analgesics, myorelaxants, and topical analgesics. Effective treatment options include intra-articular steroid injections and radiofrequency applications for blocking the suprascapular nerve (SN). The SN originates from the ventral branches of the C5-C6 brachial plexus. It is responsible for 70% of the shoulder innervation, particularly to the shoulder joint and capsule, and the acromioclavicular joint (ACJ). It provides motor innervation to the supraspinatus and infraspinatus muscles. NS block or radiofrequency applications are frequently used in the treatment of pain in shoulder joint pathologies, impingement syndrome, and ACJ pathologies. Previously, conventional radiofrequency applied at high temperatures had destructive effects on the nerve. While conventional methods are currently used in some cases, pulsed radiofrequency is effectively applied at lower temperatures, particularly to prevent motor damage . In this study, we aimed to present the effectiveness of pulsed radiofrequency (SS-PRF) application to the suprascapular nerve in a difficult and challenging patient group (elderly patients) in AC, a difficult disease to treat.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jun 2025
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2025
CompletedFirst Submitted
Initial submission to the registry
July 20, 2025
CompletedFirst Posted
Study publicly available on registry
July 28, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
August 15, 2025
CompletedSeptember 23, 2025
September 1, 2025
2 months
July 20, 2025
September 17, 2025
Conditions
Outcome Measures
Primary Outcomes (2)
numerical rating scale (NRS-11)
The NRS-11 is an 11-point numerical scale on which patients can rate their pain from 0 (no pain at all) to 10 (the most severe pain they have ever felt).
12 weeks
shoulder pain and disability index (SPADI)
The SPADI is a validated index consisting of 13 questions, 5 of which assess pain and 8 assess disability, and is scored from 0 to 100 to assess shoulder pain and functionality. As the score increases, pain and disability increase.
12 weeks
Study Arms (1)
Evaluation of the Effectiveness of Ultrasonography-Guided Pulsed Radiofrequency to the Suprascapular
Eligibility Criteria
Patients over the age of 65 who met the AK diagnostic criteria through clinical, radiological (MRI) and physical examination between June 2022 and June 2023, and who received SS-PRF treatment and who could not achieve adequate pain palliation despite medical and physical therapy modalities within an appropriate period of time, will be retrospectively screened.
You may qualify if:
- Patients over the age of 65 who were diagnosed with adhesive capsulitis through clinical physical examination and imaging and who underwent shoulder SS-PRF.
- Patients with complete data to be scanned in their files.
You may not qualify if:
- Patients with a history of shoulder surgery,
- shoulder impingement syndrome, osteoarthritis, or other primary shoulder pathologies that could explain shoulder pain,
- patients who received shoulder injections within the last 3 months,
- patients with psychosis,
- patients with pacemakers (ICDs), patients with decompensated chronic diseases,
- patients with bleeding disorders,
- patients with active malignancy or infection,
- patients with advanced cervical disc herniation,
- patients with allergies to the medications to be administered,
- patients who could not be communicated with, and patients who did not accept the procedure were excluded from the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
İKanuni Sultan Süleyman Training and Research Hospital
Küçükçekmece, Istanbul, (507) 277-4773, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
halil ibrahim altun
Kanuni Sultan Süleyman Training and Research Hospital
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- pain specialist
Study Record Dates
First Submitted
July 20, 2025
First Posted
July 28, 2025
Study Start
June 1, 2025
Primary Completion
August 1, 2025
Study Completion
August 15, 2025
Last Updated
September 23, 2025
Record last verified: 2025-09